CurrentUnitedHealthcarePolicy CS361NJ.F

Lower Extremity Prosthetics (for New Jersey Only)

This section of the UnitedHealthcare Lower Extremity Prosthetics (New Jersey) policy provides clinical evidence summaries and findings related to bone-anchored percutaneous limb prostheses, microprocessor-controlled knees (MPKs), powered hip joints, and powered/microprocessor-controlled prosthetic ankles; it informs coverage rationale and clinical considerations for prosthetic component selection.

Policy Summary

PayerUnitedHealthcare

PolicyLower Extremity Prosthetics (for New Jersey Only)

Policy CodePolicy CS361NJ.F

Change TypeAdded/Updated language (documentation, coverage determination, evidence refs)

Effective DateMar 1, 2026

Next Review Date

Key ActionEnsure member medical records include relevant history, physical exam, and test results that fully support medical necessity when requesting coverage.

SourceLink

Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.

POLICY UPDATE CHANGES

Added language clarifying that benefit coverage is determined by federal, state, or contractual requirements and applicable laws that may require coverage for a specific service.

Added language that medical records documentation may be required to assess whether the member meets clinical criteria for coverage but does not guarantee coverage.

Added requirement that the patient's medical record must contain documentation that fully supports medical necessity for requested services, including relevant history, physical exam, and pertinent test results.

Updated Clinical Evidence and References sections to reflect the most current information.

MultipleDevice types discussed

SupportiveMPK evidence for K3/K2-K3

LimitedHigh-quality RCT evidence for powered ankles

1Documentation requirement category

Evidence & ReferencesPolicy sections updated

Coverage Summary & Scope

This UnitedHealthcare New Jersey policy section (Policy Number CS361NJ.F, effective 2026-03-01) provides clinical evidence summaries for advanced lower-extremity prosthetic technologies — including bone-anchored percutaneous limb prostheses, microprocessor-controlled knees (MPKs), powered hip joints, and powered/microprocessor ankles — to inform coverage considerations. The policy takes a mixed coverage stance and summarizes available observational cohorts, randomized trials, systematic reviews, and device development studies to support clinical decision-making.

Policy metadata and scope summary

PolicyLower Extremity Prosthetics (New Jersey)

Policy NumberCS361NJ.F

Effective Date2026-03-01

StatusCURRENT

Coverage Stancemixed

Scope SummaryThis section provides clinical evidence summaries and findings related to bone-anchored percutaneous limb prostheses, microprocessor-controlled knees (MPKs), powered hip joints, and powered/microprocessor-controlled prosthetic ankles to inform coverage rationale and component selection.

Clinical Evidence and Coverage Considerations (narrative summaries)

Evidence summaries and conclusions organized by device type:

ALL of the following

Bone-anchored percutaneous limb prostheses evidence
- OPRA longitudinal studies show improved patient-reported outcomes (PROs) at 10-15 years but significant rates of mechanical complications and deep infections; limitations include lack of control group, small samples, mixed unilateral/bilateral patients, and missing device component details.
- Hagberg et al. cohort (111) with OPRA: fixture stable over 15 years; 55% had ≥1 mechanical complication; ~40% had repeated fractures; limitations: lack of control group, missing data.
- Brånemark et al. (51 TFAs) two-stage OPRA implant: 5-year cumulative fixture survival 92%; numerous adverse events including superficial skin infections, deep infections, and mechanical complications; study limited by small sample and loss to follow-up.

Medical Records Documentation & Provider Requirements

Medical Records Documentation Used for Reviews (Coverage Requirement)

Documentation may be required to assess whether the member meets clinical criteria for coverage; the medical record must contain documentation that fully supports medical necessity:

ALL of the following

Benefit coverage for health services is determined by federal, state, or contractual requirements, and applicable laws that may require coverage for a specific service
In event of conflict, federal/state/contractual requirements govern
Medical records documentation may be required to assess whether the member meets the clinical criteria for coverage but does not guarantee coverage of the service requested
ALL of the following
- Required documentation items

Coding

Referenced coding guidance (informational)mixed

No codes listed

Evidence Highlights & Key Data

This section synthesizes evidence from observational cohorts, randomized trials, systematic reviews, device development studies, and evolving evidence reviews to inform coverage decisions. Reported benefits include reduced falls and improved mobility with microprocessor-controlled knees (MPKs) in K2–K3 community ambulators and some improved mobility metrics for powered or variable-stiffness ankle-foot devices; bone-anchored (osseointegrated) prostheses demonstrated improved patient-reported outcomes in some cohorts. Significant limitations across the literature include small sample sizes, heterogeneous and often nonrandomized designs, limited comparator groups, short follow-up for many studies, and methodologic concerns (e.g., unvalidated measures, recall bias). Device-specific concerns such as high rates of mechanical complications and infections with bone-anchored implants and inconsistent or minimal-quality evidence for powered microprocessor ankles further constrain conclusions and support caution in routine coverage without individualized justification.

Selected evidence items

OPRA 10-year revision-free survival ratesimplant revision 83% (CI 69%-91%), deep infection 65% (CI 49%-77%), mechanical complications 17% (CI 7%-29%)

Klenow et al. (2024) stumble reduction85% reduction in stumble frequency (16.0 ±39.7 to 2.4 ±2.3; p=0.008)

Rogers-Bradley et al. (2024) COM push-off work increaseIncrease of 26.1%-29.9% across speeds for VSA vs passive

Definitions

Term	Definition
MFCL / K-level	Medicare Functional Classification Level describing patient ambulatory potential (K0-K4).
MPK	Microprocessor-controlled prosthetic knee.
PwrAF / MPA	Powered ankle-foot prosthesis / Microprocessor prosthetic ankle.
MPA	Microprocessor (or powered microprocessor) prosthetic ankle
PwrAF	Powered prosthetic ankle-foot
TTA	Transtibial amputation
K3	Medicare Functional Classification Level indicating community ambulation ability

Medicare Determinations

Name	Number	Type	Effective Date
CMS HCPCS reference		neutral

Revision History

03/01/2026added (material)Latest

Added language clarifying that benefit coverage is determined by federal, state, or contractual requirements and applicable laws that may require coverage for a specific service.

03/01/2026added (material)Latest

Added language that medical records documentation may be required to assess whether the member meets clinical criteria for coverage but does not guarantee coverage.

Policy Summary

PayerUnitedHealthcare

PolicyLower Extremity Prosthetics (for New Jersey Only)

Policy CodePolicy CS361NJ.F

Change TypeAdded/Updated language (documentation, coverage determination, evidence refs)

Effective DateMar 1, 2026

Next Review Date

Key ActionEnsure member medical records include relevant history, physical exam, and test results that fully support medical necessity when requesting coverage.

SourceLink

On This Page

Microprocessor-controlled knee prostheses (MPK) evidence

There is ample literature supporting efficacy of MPKs in community ambulators (MFCL K3); insufficient evidence for lower functional levels.
Klenow et al. (2024) RCT (n=26) enhancements to Genium/Genium X3 reduced stumbles 85%; improvements in pain for unilateral group; limitations: small sample, possible underpowering, heterogenous sample, unvalidated measures.
Morgan et al. (2024) pilot RCT in early rehabilitation (n=18 enrolled, 15 completed): MPK users had better 3-month outcomes (PLSOM, ABC, RNL Index) versus NMPK; small sample limits conclusions.
Tacca et al. (2024) transtibial study on powered BiOM settings showed biomechanical changes by stiffness and power; small sample and limited accommodation time.
Alzeer et al. (2022) comparative hospital study (n=76) showed MCPK improved gait, ADLs, QoL vs NMCPK; limitations: homogeneous population, self-report measures.
Jayaraman et al. (2021) crossover RCT in dysvascular unilateral TFAs (MFCL K1-K2) found gait/balance/mobility benefits with MPK vs NMPK; small sample and younger mean age limit generalizability.
Systematic reviews/meta-analyses (Hahn et al. 2021; AHRQ 2018; Kannenberg et al. 2014) indicate MPKs reduce falls and improve mobility in limited community ambulators (K2) and K3 users, but evidence is from small, heterogeneous studies with methodological limitations.
Theeven et al. (2011) randomized cross-over (n=41) in MFCL-2 found variable individual responses to different MPK devices, supporting individualized trial fittings.

Microprocessor controlled powered hip joint prosthesis

Brannen et al. (2025) prototype PHP met many design and strength criteria (ISO testing), supported level walking in able-bodied simulator users, but protruded anteriorly more than target and had limited functional testing (n=3); further design optimization and evaluation needed.

Powered microprocessor prosthetic ankles (MPA/PwrAF) evidence

Insufficient clinical evidence to support routine use of powered MPAs for transtibial amputations; Hayes reviews (2022-2024) indicate minimal support with inconsistent findings and small/poor-quality studies.
Herrin et al. (2024) small uncontrolled study identified gait metrics distinguishing tuned vs untuned powered prosthetic foot performance; indicates potential value of biomechanical data for tuning but limited by sample size.
Rogers-Bradley et al. (2024) small comparison of variable-stiffness ankle-foot (VSA) vs passive prosthesis showed increased prosthetic-side energy return and decreased contralateral peak ground reaction force at certain speeds; limitations: small sample and treadmill speed constraints.
Kannenberg et al. (2022) cross-sectional pragmatic study of 250 TTA fitted with PwrAF (study text truncated here) exploring musculoskeletal pain and mobility; study referenced but details not fully included in this part.

AHRQ summary: AHRQ (2018) LLP review identified gaps: many outcome measures with variable validity/reliability; limited comparative studies; insufficient long-term follow-up and heterogeneity in populations; calls for robust studies with stratification by amputation level, etiology, baseline K-level.

Relevant medical history

Physical examination

Results of pertinent diagnostic tests or procedures

Documentation supporting medical necessity should be legible, maintained in the patient's medical record, and made available upon request

Documentation Required

Need for individualized trial fittings and documentation of functional level

Evidence supports trial fittings for MPKs and individualized assessment (e.g., ADAPT, MFCL/K-level documentation) because benefits vary among patients; document trial findings, functional classification, and justification for advanced components.

Perform individualized trial fitting for the patient (document ADAPT or equivalent trial results).
Record MFCL / K-level and any changes observed during the trial.
Document objective and patient-reported outcomes from the trial (e.g., mobility, falls, ADLs).
Provide justification for advanced components based on trial results and functional needs.

Prior Authorization

Potential requirement for justification for advanced prosthetic components

Given evidence limitations and higher complication risks for some devices and novel components, submit a detailed clinical rationale when requesting coverage. Include prior trial results and a risk/benefit discussion for novel or high-risk prosthetic components.

Provide prior trial fitting results and objective measures of benefit or lack of benefit.
Summarize relevant clinical evidence and patient-specific factors supporting the request.
Include a discussion of potential risks, complications, and anticipated benefits for the member.

Documentation Required

Provide complete medical records for coverage review

Ensure member medical records include relevant medical history, physical examination, and results of pertinent diagnostic tests or procedures. Documentation must fully support medical necessity and be made available upon request; medical record submission may be required to assess whether the member meets clinical criteria but does not guarantee coverage.

Include pertinent medical history related to amputation, comorbidities, and functional status.
Provide physical exam findings and MFCL / K-level assessment documentation.
Attach results of relevant diagnostic tests, functional outcome measures, and trial fitting data.
Make records legible, maintained in the patient's chart, and available upon request.

Prior Authorization

Coverage subject to federal/state/contractual rules

Verify applicable federal, state, or contractual benefit requirements before applying this policy. In the event of a conflict, federal, state, or contractual requirements govern coverage decisions.

Check member's federal, state, or contractual plan terms prior to authorization or denial.
Follow governing requirements where they differ from this policy.

Hayes evolving evidence review (2022, updated 2024)Minimal support for powered MPAs; reviewed 3 poor/very poor quality studies; updates in 2023-2024 did not change conclusions

Kannenberg et al. (2022)Cross-sectional survey (n=46 analyzed; 18 current users) found current PwrAF users reported improvements in knee pain and mobility vs recalled passive foot; limitations include recall bias and small, male-only sample

Kim et al. (2021)Randomized trial (n=12) comparing powered vs unpowered prosthesis found no significant differences in metabolic cost, activity, walking speed, or perceived mobility; small sample

VA/DoD CPG noteGuideline (2017, updated 2025) suggests microprocessor knees over non-microprocessor knees to reduce falls and optimize mobility; osseointegration suggested as an option for transfemoral amputees (weak recommendation)

03/01/2026revised (archival note, non-material)

Archived previous policy version CS361NJ.E.

03/01/2026revised (references)Latest

Updated Clinical Evidence and References sections to reflect the most current information.